Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 23, 2008Cochrane library

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

View Full Paper
Ask AI
Bookmark
Share

Authors

BBBrian W. BehmUniversity of VirginiaSBStephen J. BickstonVirginia Commonwealth University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Behm et al. (2008) studied this question.

synapsesocial.com/papers/6ab244dad203963c32bf4fcchttps://doi.org/10.1002/14651858.cd006893
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease2003 · 135 citations
  2. 2Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies2006 · 2,485 citations
  3. 3CDP571, a humanized monoclonal antibody to tumour necrosis factor‐α, for steroid‐dependent Crohn's disease: a randomized, double‐blind, placebo‐controlled trial2006 · 44 citations